Oncogenes in head and neck cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Head and neck squamous cell carcinomas (HNSCC) are a significant group of cancers.
• Understanding the molecular alterations driving HNSCC is crucial for improved diagnostics and prognostics.

Purpose of the Study:

• To investigate alterations in K-ras, raf, and erb-B oncogenes in primary HNSCC.
• To evaluate the potential of epidermal growth factor receptor (EGFR) as a diagnostic and prognostic marker in HNSCC.

Main Methods:

• Sequence analysis and polymerase chain reaction (PCR) for K-ras mutations.
• Southern blot analysis for raf gene activation.
• Analysis of EGFR gene amplification/rearrangement and erb-B gene overexpression.

Main Results:

• No mutations were detected in the K-ras or c-raf oncogenes.
• Epidermal Growth Factor Receptor (EGFR) gene amplification/rearrangement was observed in 13% of HNSCC tumors.
• Overexpression of the erb-B gene was found in 67% of studied HNSCC tumors.
• Higher EGFR levels or amplification correlated with clinically advanced tumors.

Conclusions:

• Amplification and overexpression of the EGFR gene are potential diagnostic and prognostic markers for HNSCC.
• K-ras and raf oncogenes do not appear to be significantly altered in the studied HNSCC cohort.
• EGFR alterations may play a key role in the progression of head and neck squamous cell carcinomas.